Global Neuroscience Antibodies and Assays Supply, Demand and Key Producers, 2023-2029

Global Neuroscience Antibodies and Assays Supply, Demand and Key Producers, 2023-2029

Page: 112

Published Date: 29 Jan 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The demand for Neuroscience Antibodies and Assays is increasing, due to the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries.

This report studies the global Neuroscience Antibodies and Assays demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Neuroscience Antibodies and Assays, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Neuroscience Antibodies and Assays that contribute to its increasing demand across many markets.

The global Neuroscience Antibodies and Assays market size is expected to reach $ 3627.5 million by 2029, rising at a market growth of 5.6% CAGR during the forecast period (2023-2029).

Highlights and key features of the study
Global Neuroscience Antibodies and Assays total market, 2018-2029, (USD Million)
Global Neuroscience Antibodies and Assays total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Neuroscience Antibodies and Assays total market, key domestic companies and share, (USD Million)
Global Neuroscience Antibodies and Assays revenue by player and market share 2018-2023, (USD Million)
Global Neuroscience Antibodies and Assays total market by Type, CAGR, 2018-2029, (USD Million)
Global Neuroscience Antibodies and Assays total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Neuroscience Antibodies and Assays market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher, Abcam, Bio-Rad, Merck, Cell Signaling Technology, Genscript, Rockland Immunochemicals, BioLegend and Santa Cruz Biotechnology, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Neuroscience Antibodies and Assays market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Neuroscience Antibodies and Assays Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Neuroscience Antibodies and Assays Market, Segmentation by Type
Consumables
Instruments

Global Neuroscience Antibodies and Assays Market, Segmentation by Application
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Hospitals & Diagnostic Centers

Companies Profiled:
Thermo Fisher
Abcam
Bio-Rad
Merck
Cell Signaling Technology
Genscript
Rockland Immunochemicals
BioLegend
Santa Cruz Biotechnology
Roche
Siemens

Key Questions Answered
1. How big is the global Neuroscience Antibodies and Assays market?
2. What is the demand of the global Neuroscience Antibodies and Assays market?
3. What is the year over year growth of the global Neuroscience Antibodies and Assays market?
4. What is the total value of the global Neuroscience Antibodies and Assays market?
5. Who are the major players in the global Neuroscience Antibodies and Assays market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Neuroscience Antibodies and Assays Introduction
1.2 World Neuroscience Antibodies and Assays Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Neuroscience Antibodies and Assays Total Market by Region (by Headquarter Location)
1.3.1 World Neuroscience Antibodies and Assays Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Neuroscience Antibodies and Assays Market Size (2018-2029)
1.3.3 China Neuroscience Antibodies and Assays Market Size (2018-2029)
1.3.4 Europe Neuroscience Antibodies and Assays Market Size (2018-2029)
1.3.5 Japan Neuroscience Antibodies and Assays Market Size (2018-2029)
1.3.6 South Korea Neuroscience Antibodies and Assays Market Size (2018-2029)
1.3.7 ASEAN Neuroscience Antibodies and Assays Market Size (2018-2029)
1.3.8 India Neuroscience Antibodies and Assays Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Neuroscience Antibodies and Assays Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Neuroscience Antibodies and Assays Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World Neuroscience Antibodies and Assays Consumption Value (2018-2029)
2.2 World Neuroscience Antibodies and Assays Consumption Value by Region
2.2.1 World Neuroscience Antibodies and Assays Consumption Value by Region (2018-2023)
2.2.2 World Neuroscience Antibodies and Assays Consumption Value Forecast by Region (2024-2029)
2.3 United States Neuroscience Antibodies and Assays Consumption Value (2018-2029)
2.4 China Neuroscience Antibodies and Assays Consumption Value (2018-2029)
2.5 Europe Neuroscience Antibodies and Assays Consumption Value (2018-2029)
2.6 Japan Neuroscience Antibodies and Assays Consumption Value (2018-2029)
2.7 South Korea Neuroscience Antibodies and Assays Consumption Value (2018-2029)
2.8 ASEAN Neuroscience Antibodies and Assays Consumption Value (2018-2029)
2.9 India Neuroscience Antibodies and Assays Consumption Value (2018-2029)

3 World Neuroscience Antibodies and Assays Companies Competitive Analysis
3.1 World Neuroscience Antibodies and Assays Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Neuroscience Antibodies and Assays Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Neuroscience Antibodies and Assays in 2022
3.2.3 Global Concentration Ratios (CR8) for Neuroscience Antibodies and Assays in 2022
3.3 Neuroscience Antibodies and Assays Company Evaluation Quadrant
3.4 Neuroscience Antibodies and Assays Market: Overall Company Footprint Analysis
3.4.1 Neuroscience Antibodies and Assays Market: Region Footprint
3.4.2 Neuroscience Antibodies and Assays Market: Company Product Type Footprint
3.4.3 Neuroscience Antibodies and Assays Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: Neuroscience Antibodies and Assays Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Neuroscience Antibodies and Assays Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Neuroscience Antibodies and Assays Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Neuroscience Antibodies and Assays Consumption Value Comparison
4.2.1 United States VS China: Neuroscience Antibodies and Assays Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Neuroscience Antibodies and Assays Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Neuroscience Antibodies and Assays Companies and Market Share, 2018-2023
4.3.1 United States Based Neuroscience Antibodies and Assays Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Neuroscience Antibodies and Assays Revenue, (2018-2023)
4.4 China Based Companies Neuroscience Antibodies and Assays Revenue and Market Share, 2018-2023
4.4.1 China Based Neuroscience Antibodies and Assays Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Neuroscience Antibodies and Assays Revenue, (2018-2023)
4.5 Rest of World Based Neuroscience Antibodies and Assays Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Neuroscience Antibodies and Assays Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Neuroscience Antibodies and Assays Revenue, (2018-2023)

5 Market Analysis by Type
5.1 World Neuroscience Antibodies and Assays Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Consumables
5.2.2 Instruments
5.3 Market Segment by Type
5.3.1 World Neuroscience Antibodies and Assays Market Size by Type (2018-2023)
5.3.2 World Neuroscience Antibodies and Assays Market Size by Type (2024-2029)
5.3.3 World Neuroscience Antibodies and Assays Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
6.1 World Neuroscience Antibodies and Assays Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical & Biotechnology Companies
6.2.2 Academic & Research Institutes
6.2.3 Hospitals & Diagnostic Centers
6.3 Market Segment by Application
6.3.1 World Neuroscience Antibodies and Assays Market Size by Application (2018-2023)
6.3.2 World Neuroscience Antibodies and Assays Market Size by Application (2024-2029)
6.3.3 World Neuroscience Antibodies and Assays Market Size by Application (2018-2029)

7 Company Profiles
7.1 Thermo Fisher
7.1.1 Thermo Fisher Details
7.1.2 Thermo Fisher Major Business
7.1.3 Thermo Fisher Neuroscience Antibodies and Assays Product and Services
7.1.4 Thermo Fisher Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Thermo Fisher Recent Developments/Updates
7.1.6 Thermo Fisher Competitive Strengths & Weaknesses
7.2 Abcam
7.2.1 Abcam Details
7.2.2 Abcam Major Business
7.2.3 Abcam Neuroscience Antibodies and Assays Product and Services
7.2.4 Abcam Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Abcam Recent Developments/Updates
7.2.6 Abcam Competitive Strengths & Weaknesses
7.3 Bio-Rad
7.3.1 Bio-Rad Details
7.3.2 Bio-Rad Major Business
7.3.3 Bio-Rad Neuroscience Antibodies and Assays Product and Services
7.3.4 Bio-Rad Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Bio-Rad Recent Developments/Updates
7.3.6 Bio-Rad Competitive Strengths & Weaknesses
7.4 Merck
7.4.1 Merck Details
7.4.2 Merck Major Business
7.4.3 Merck Neuroscience Antibodies and Assays Product and Services
7.4.4 Merck Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Merck Recent Developments/Updates
7.4.6 Merck Competitive Strengths & Weaknesses
7.5 Cell Signaling Technology
7.5.1 Cell Signaling Technology Details
7.5.2 Cell Signaling Technology Major Business
7.5.3 Cell Signaling Technology Neuroscience Antibodies and Assays Product and Services
7.5.4 Cell Signaling Technology Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Cell Signaling Technology Recent Developments/Updates
7.5.6 Cell Signaling Technology Competitive Strengths & Weaknesses
7.6 Genscript
7.6.1 Genscript Details
7.6.2 Genscript Major Business
7.6.3 Genscript Neuroscience Antibodies and Assays Product and Services
7.6.4 Genscript Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Genscript Recent Developments/Updates
7.6.6 Genscript Competitive Strengths & Weaknesses
7.7 Rockland Immunochemicals
7.7.1 Rockland Immunochemicals Details
7.7.2 Rockland Immunochemicals Major Business
7.7.3 Rockland Immunochemicals Neuroscience Antibodies and Assays Product and Services
7.7.4 Rockland Immunochemicals Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Rockland Immunochemicals Recent Developments/Updates
7.7.6 Rockland Immunochemicals Competitive Strengths & Weaknesses
7.8 BioLegend
7.8.1 BioLegend Details
7.8.2 BioLegend Major Business
7.8.3 BioLegend Neuroscience Antibodies and Assays Product and Services
7.8.4 BioLegend Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 BioLegend Recent Developments/Updates
7.8.6 BioLegend Competitive Strengths & Weaknesses
7.9 Santa Cruz Biotechnology
7.9.1 Santa Cruz Biotechnology Details
7.9.2 Santa Cruz Biotechnology Major Business
7.9.3 Santa Cruz Biotechnology Neuroscience Antibodies and Assays Product and Services
7.9.4 Santa Cruz Biotechnology Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Santa Cruz Biotechnology Recent Developments/Updates
7.9.6 Santa Cruz Biotechnology Competitive Strengths & Weaknesses
7.10 Roche
7.10.1 Roche Details
7.10.2 Roche Major Business
7.10.3 Roche Neuroscience Antibodies and Assays Product and Services
7.10.4 Roche Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Roche Recent Developments/Updates
7.10.6 Roche Competitive Strengths & Weaknesses
7.11 Siemens
7.11.1 Siemens Details
7.11.2 Siemens Major Business
7.11.3 Siemens Neuroscience Antibodies and Assays Product and Services
7.11.4 Siemens Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Siemens Recent Developments/Updates
7.11.6 Siemens Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Neuroscience Antibodies and Assays Industry Chain
8.2 Neuroscience Antibodies and Assays Upstream Analysis
8.3 Neuroscience Antibodies and Assays Midstream Analysis
8.4 Neuroscience Antibodies and Assays Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Neuroscience Antibodies and Assays Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Neuroscience Antibodies and Assays Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Neuroscience Antibodies and Assays Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Neuroscience Antibodies and Assays Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Neuroscience Antibodies and Assays Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Neuroscience Antibodies and Assays Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Neuroscience Antibodies and Assays Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Neuroscience Antibodies and Assays Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Neuroscience Antibodies and Assays Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Neuroscience Antibodies and Assays Players in 2022
Table 12. World Neuroscience Antibodies and Assays Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Neuroscience Antibodies and Assays Company Evaluation Quadrant
Table 14. Head Office of Key Neuroscience Antibodies and Assays Player
Table 15. Neuroscience Antibodies and Assays Market: Company Product Type Footprint
Table 16. Neuroscience Antibodies and Assays Market: Company Product Application Footprint
Table 17. Neuroscience Antibodies and Assays Mergers & Acquisitions Activity
Table 18. United States VS China Neuroscience Antibodies and Assays Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Neuroscience Antibodies and Assays Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Neuroscience Antibodies and Assays Companies, Headquarters (States, Country)
Table 21. United States Based Companies Neuroscience Antibodies and Assays Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Neuroscience Antibodies and Assays Revenue Market Share (2018-2023)
Table 23. China Based Neuroscience Antibodies and Assays Companies, Headquarters (Province, Country)
Table 24. China Based Companies Neuroscience Antibodies and Assays Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Neuroscience Antibodies and Assays Revenue Market Share (2018-2023)
Table 26. Rest of World Based Neuroscience Antibodies and Assays Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Neuroscience Antibodies and Assays Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Neuroscience Antibodies and Assays Revenue Market Share (2018-2023)
Table 29. World Neuroscience Antibodies and Assays Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Neuroscience Antibodies and Assays Market Size by Type (2018-2023) & (USD Million)
Table 31. World Neuroscience Antibodies and Assays Market Size by Type (2024-2029) & (USD Million)
Table 32. World Neuroscience Antibodies and Assays Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Neuroscience Antibodies and Assays Market Size by Application (2018-2023) & (USD Million)
Table 34. World Neuroscience Antibodies and Assays Market Size by Application (2024-2029) & (USD Million)
Table 35. Thermo Fisher Basic Information, Area Served and Competitors
Table 36. Thermo Fisher Major Business
Table 37. Thermo Fisher Neuroscience Antibodies and Assays Product and Services
Table 38. Thermo Fisher Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Thermo Fisher Recent Developments/Updates
Table 40. Thermo Fisher Competitive Strengths & Weaknesses
Table 41. Abcam Basic Information, Area Served and Competitors
Table 42. Abcam Major Business
Table 43. Abcam Neuroscience Antibodies and Assays Product and Services
Table 44. Abcam Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Abcam Recent Developments/Updates
Table 46. Abcam Competitive Strengths & Weaknesses
Table 47. Bio-Rad Basic Information, Area Served and Competitors
Table 48. Bio-Rad Major Business
Table 49. Bio-Rad Neuroscience Antibodies and Assays Product and Services
Table 50. Bio-Rad Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Bio-Rad Recent Developments/Updates
Table 52. Bio-Rad Competitive Strengths & Weaknesses
Table 53. Merck Basic Information, Area Served and Competitors
Table 54. Merck Major Business
Table 55. Merck Neuroscience Antibodies and Assays Product and Services
Table 56. Merck Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Merck Recent Developments/Updates
Table 58. Merck Competitive Strengths & Weaknesses
Table 59. Cell Signaling Technology Basic Information, Area Served and Competitors
Table 60. Cell Signaling Technology Major Business
Table 61. Cell Signaling Technology Neuroscience Antibodies and Assays Product and Services
Table 62. Cell Signaling Technology Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Cell Signaling Technology Recent Developments/Updates
Table 64. Cell Signaling Technology Competitive Strengths & Weaknesses
Table 65. Genscript Basic Information, Area Served and Competitors
Table 66. Genscript Major Business
Table 67. Genscript Neuroscience Antibodies and Assays Product and Services
Table 68. Genscript Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Genscript Recent Developments/Updates
Table 70. Genscript Competitive Strengths & Weaknesses
Table 71. Rockland Immunochemicals Basic Information, Area Served and Competitors
Table 72. Rockland Immunochemicals Major Business
Table 73. Rockland Immunochemicals Neuroscience Antibodies and Assays Product and Services
Table 74. Rockland Immunochemicals Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Rockland Immunochemicals Recent Developments/Updates
Table 76. Rockland Immunochemicals Competitive Strengths & Weaknesses
Table 77. BioLegend Basic Information, Area Served and Competitors
Table 78. BioLegend Major Business
Table 79. BioLegend Neuroscience Antibodies and Assays Product and Services
Table 80. BioLegend Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. BioLegend Recent Developments/Updates
Table 82. BioLegend Competitive Strengths & Weaknesses
Table 83. Santa Cruz Biotechnology Basic Information, Area Served and Competitors
Table 84. Santa Cruz Biotechnology Major Business
Table 85. Santa Cruz Biotechnology Neuroscience Antibodies and Assays Product and Services
Table 86. Santa Cruz Biotechnology Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Santa Cruz Biotechnology Recent Developments/Updates
Table 88. Santa Cruz Biotechnology Competitive Strengths & Weaknesses
Table 89. Roche Basic Information, Area Served and Competitors
Table 90. Roche Major Business
Table 91. Roche Neuroscience Antibodies and Assays Product and Services
Table 92. Roche Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Roche Recent Developments/Updates
Table 94. Siemens Basic Information, Area Served and Competitors
Table 95. Siemens Major Business
Table 96. Siemens Neuroscience Antibodies and Assays Product and Services
Table 97. Siemens Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 98. Global Key Players of Neuroscience Antibodies and Assays Upstream (Raw Materials)
Table 99. Neuroscience Antibodies and Assays Typical Customers
List of Figure
Figure 1. Neuroscience Antibodies and Assays Picture
Figure 2. World Neuroscience Antibodies and Assays Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Neuroscience Antibodies and Assays Total Market Size (2018-2029) & (USD Million)
Figure 4. World Neuroscience Antibodies and Assays Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Neuroscience Antibodies and Assays Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Neuroscience Antibodies and Assays Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Neuroscience Antibodies and Assays Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Neuroscience Antibodies and Assays Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Neuroscience Antibodies and Assays Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Neuroscience Antibodies and Assays Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Neuroscience Antibodies and Assays Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Neuroscience Antibodies and Assays Revenue (2018-2029) & (USD Million)
Figure 13. Neuroscience Antibodies and Assays Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
Figure 16. World Neuroscience Antibodies and Assays Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
Figure 18. China Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
Figure 23. India Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Neuroscience Antibodies and Assays by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Neuroscience Antibodies and Assays Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Neuroscience Antibodies and Assays Markets in 2022
Figure 27. United States VS China: Neuroscience Antibodies and Assays Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Neuroscience Antibodies and Assays Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Neuroscience Antibodies and Assays Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Neuroscience Antibodies and Assays Market Size Market Share by Type in 2022
Figure 31. Consumables
Figure 32. Instruments
Figure 33. World Neuroscience Antibodies and Assays Market Size Market Share by Type (2018-2029)
Figure 34. World Neuroscience Antibodies and Assays Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Neuroscience Antibodies and Assays Market Size Market Share by Application in 2022
Figure 36. Pharmaceutical & Biotechnology Companies
Figure 37. Academic & Research Institutes
Figure 38. Hospitals & Diagnostic Centers
Figure 39. Neuroscience Antibodies and Assays Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Neuroscience Antibodies and Assays Supply, Demand and Key Producers, 2023-2029

Global Neuroscience Antibodies and Assays Supply, Demand and Key Producers, 2023-2029

Page: 112

Published Date: 29 Jan 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The demand for Neuroscience Antibodies and Assays is increasing, due to the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries.

This report studies the global Neuroscience Antibodies and Assays demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Neuroscience Antibodies and Assays, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Neuroscience Antibodies and Assays that contribute to its increasing demand across many markets.

The global Neuroscience Antibodies and Assays market size is expected to reach $ 3627.5 million by 2029, rising at a market growth of 5.6% CAGR during the forecast period (2023-2029).

Highlights and key features of the study
Global Neuroscience Antibodies and Assays total market, 2018-2029, (USD Million)
Global Neuroscience Antibodies and Assays total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Neuroscience Antibodies and Assays total market, key domestic companies and share, (USD Million)
Global Neuroscience Antibodies and Assays revenue by player and market share 2018-2023, (USD Million)
Global Neuroscience Antibodies and Assays total market by Type, CAGR, 2018-2029, (USD Million)
Global Neuroscience Antibodies and Assays total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Neuroscience Antibodies and Assays market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher, Abcam, Bio-Rad, Merck, Cell Signaling Technology, Genscript, Rockland Immunochemicals, BioLegend and Santa Cruz Biotechnology, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Neuroscience Antibodies and Assays market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Neuroscience Antibodies and Assays Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Neuroscience Antibodies and Assays Market, Segmentation by Type
Consumables
Instruments

Global Neuroscience Antibodies and Assays Market, Segmentation by Application
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Hospitals & Diagnostic Centers

Companies Profiled:
Thermo Fisher
Abcam
Bio-Rad
Merck
Cell Signaling Technology
Genscript
Rockland Immunochemicals
BioLegend
Santa Cruz Biotechnology
Roche
Siemens

Key Questions Answered
1. How big is the global Neuroscience Antibodies and Assays market?
2. What is the demand of the global Neuroscience Antibodies and Assays market?
3. What is the year over year growth of the global Neuroscience Antibodies and Assays market?
4. What is the total value of the global Neuroscience Antibodies and Assays market?
5. Who are the major players in the global Neuroscience Antibodies and Assays market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Neuroscience Antibodies and Assays Introduction
1.2 World Neuroscience Antibodies and Assays Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Neuroscience Antibodies and Assays Total Market by Region (by Headquarter Location)
1.3.1 World Neuroscience Antibodies and Assays Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Neuroscience Antibodies and Assays Market Size (2018-2029)
1.3.3 China Neuroscience Antibodies and Assays Market Size (2018-2029)
1.3.4 Europe Neuroscience Antibodies and Assays Market Size (2018-2029)
1.3.5 Japan Neuroscience Antibodies and Assays Market Size (2018-2029)
1.3.6 South Korea Neuroscience Antibodies and Assays Market Size (2018-2029)
1.3.7 ASEAN Neuroscience Antibodies and Assays Market Size (2018-2029)
1.3.8 India Neuroscience Antibodies and Assays Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Neuroscience Antibodies and Assays Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Neuroscience Antibodies and Assays Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World Neuroscience Antibodies and Assays Consumption Value (2018-2029)
2.2 World Neuroscience Antibodies and Assays Consumption Value by Region
2.2.1 World Neuroscience Antibodies and Assays Consumption Value by Region (2018-2023)
2.2.2 World Neuroscience Antibodies and Assays Consumption Value Forecast by Region (2024-2029)
2.3 United States Neuroscience Antibodies and Assays Consumption Value (2018-2029)
2.4 China Neuroscience Antibodies and Assays Consumption Value (2018-2029)
2.5 Europe Neuroscience Antibodies and Assays Consumption Value (2018-2029)
2.6 Japan Neuroscience Antibodies and Assays Consumption Value (2018-2029)
2.7 South Korea Neuroscience Antibodies and Assays Consumption Value (2018-2029)
2.8 ASEAN Neuroscience Antibodies and Assays Consumption Value (2018-2029)
2.9 India Neuroscience Antibodies and Assays Consumption Value (2018-2029)

3 World Neuroscience Antibodies and Assays Companies Competitive Analysis
3.1 World Neuroscience Antibodies and Assays Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Neuroscience Antibodies and Assays Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Neuroscience Antibodies and Assays in 2022
3.2.3 Global Concentration Ratios (CR8) for Neuroscience Antibodies and Assays in 2022
3.3 Neuroscience Antibodies and Assays Company Evaluation Quadrant
3.4 Neuroscience Antibodies and Assays Market: Overall Company Footprint Analysis
3.4.1 Neuroscience Antibodies and Assays Market: Region Footprint
3.4.2 Neuroscience Antibodies and Assays Market: Company Product Type Footprint
3.4.3 Neuroscience Antibodies and Assays Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: Neuroscience Antibodies and Assays Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Neuroscience Antibodies and Assays Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Neuroscience Antibodies and Assays Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Neuroscience Antibodies and Assays Consumption Value Comparison
4.2.1 United States VS China: Neuroscience Antibodies and Assays Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Neuroscience Antibodies and Assays Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Neuroscience Antibodies and Assays Companies and Market Share, 2018-2023
4.3.1 United States Based Neuroscience Antibodies and Assays Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Neuroscience Antibodies and Assays Revenue, (2018-2023)
4.4 China Based Companies Neuroscience Antibodies and Assays Revenue and Market Share, 2018-2023
4.4.1 China Based Neuroscience Antibodies and Assays Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Neuroscience Antibodies and Assays Revenue, (2018-2023)
4.5 Rest of World Based Neuroscience Antibodies and Assays Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Neuroscience Antibodies and Assays Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Neuroscience Antibodies and Assays Revenue, (2018-2023)

5 Market Analysis by Type
5.1 World Neuroscience Antibodies and Assays Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Consumables
5.2.2 Instruments
5.3 Market Segment by Type
5.3.1 World Neuroscience Antibodies and Assays Market Size by Type (2018-2023)
5.3.2 World Neuroscience Antibodies and Assays Market Size by Type (2024-2029)
5.3.3 World Neuroscience Antibodies and Assays Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
6.1 World Neuroscience Antibodies and Assays Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical & Biotechnology Companies
6.2.2 Academic & Research Institutes
6.2.3 Hospitals & Diagnostic Centers
6.3 Market Segment by Application
6.3.1 World Neuroscience Antibodies and Assays Market Size by Application (2018-2023)
6.3.2 World Neuroscience Antibodies and Assays Market Size by Application (2024-2029)
6.3.3 World Neuroscience Antibodies and Assays Market Size by Application (2018-2029)

7 Company Profiles
7.1 Thermo Fisher
7.1.1 Thermo Fisher Details
7.1.2 Thermo Fisher Major Business
7.1.3 Thermo Fisher Neuroscience Antibodies and Assays Product and Services
7.1.4 Thermo Fisher Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Thermo Fisher Recent Developments/Updates
7.1.6 Thermo Fisher Competitive Strengths & Weaknesses
7.2 Abcam
7.2.1 Abcam Details
7.2.2 Abcam Major Business
7.2.3 Abcam Neuroscience Antibodies and Assays Product and Services
7.2.4 Abcam Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Abcam Recent Developments/Updates
7.2.6 Abcam Competitive Strengths & Weaknesses
7.3 Bio-Rad
7.3.1 Bio-Rad Details
7.3.2 Bio-Rad Major Business
7.3.3 Bio-Rad Neuroscience Antibodies and Assays Product and Services
7.3.4 Bio-Rad Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Bio-Rad Recent Developments/Updates
7.3.6 Bio-Rad Competitive Strengths & Weaknesses
7.4 Merck
7.4.1 Merck Details
7.4.2 Merck Major Business
7.4.3 Merck Neuroscience Antibodies and Assays Product and Services
7.4.4 Merck Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Merck Recent Developments/Updates
7.4.6 Merck Competitive Strengths & Weaknesses
7.5 Cell Signaling Technology
7.5.1 Cell Signaling Technology Details
7.5.2 Cell Signaling Technology Major Business
7.5.3 Cell Signaling Technology Neuroscience Antibodies and Assays Product and Services
7.5.4 Cell Signaling Technology Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Cell Signaling Technology Recent Developments/Updates
7.5.6 Cell Signaling Technology Competitive Strengths & Weaknesses
7.6 Genscript
7.6.1 Genscript Details
7.6.2 Genscript Major Business
7.6.3 Genscript Neuroscience Antibodies and Assays Product and Services
7.6.4 Genscript Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Genscript Recent Developments/Updates
7.6.6 Genscript Competitive Strengths & Weaknesses
7.7 Rockland Immunochemicals
7.7.1 Rockland Immunochemicals Details
7.7.2 Rockland Immunochemicals Major Business
7.7.3 Rockland Immunochemicals Neuroscience Antibodies and Assays Product and Services
7.7.4 Rockland Immunochemicals Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Rockland Immunochemicals Recent Developments/Updates
7.7.6 Rockland Immunochemicals Competitive Strengths & Weaknesses
7.8 BioLegend
7.8.1 BioLegend Details
7.8.2 BioLegend Major Business
7.8.3 BioLegend Neuroscience Antibodies and Assays Product and Services
7.8.4 BioLegend Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 BioLegend Recent Developments/Updates
7.8.6 BioLegend Competitive Strengths & Weaknesses
7.9 Santa Cruz Biotechnology
7.9.1 Santa Cruz Biotechnology Details
7.9.2 Santa Cruz Biotechnology Major Business
7.9.3 Santa Cruz Biotechnology Neuroscience Antibodies and Assays Product and Services
7.9.4 Santa Cruz Biotechnology Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Santa Cruz Biotechnology Recent Developments/Updates
7.9.6 Santa Cruz Biotechnology Competitive Strengths & Weaknesses
7.10 Roche
7.10.1 Roche Details
7.10.2 Roche Major Business
7.10.3 Roche Neuroscience Antibodies and Assays Product and Services
7.10.4 Roche Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Roche Recent Developments/Updates
7.10.6 Roche Competitive Strengths & Weaknesses
7.11 Siemens
7.11.1 Siemens Details
7.11.2 Siemens Major Business
7.11.3 Siemens Neuroscience Antibodies and Assays Product and Services
7.11.4 Siemens Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Siemens Recent Developments/Updates
7.11.6 Siemens Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Neuroscience Antibodies and Assays Industry Chain
8.2 Neuroscience Antibodies and Assays Upstream Analysis
8.3 Neuroscience Antibodies and Assays Midstream Analysis
8.4 Neuroscience Antibodies and Assays Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Neuroscience Antibodies and Assays Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Neuroscience Antibodies and Assays Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Neuroscience Antibodies and Assays Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Neuroscience Antibodies and Assays Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Neuroscience Antibodies and Assays Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Neuroscience Antibodies and Assays Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Neuroscience Antibodies and Assays Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Neuroscience Antibodies and Assays Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Neuroscience Antibodies and Assays Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Neuroscience Antibodies and Assays Players in 2022
Table 12. World Neuroscience Antibodies and Assays Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Neuroscience Antibodies and Assays Company Evaluation Quadrant
Table 14. Head Office of Key Neuroscience Antibodies and Assays Player
Table 15. Neuroscience Antibodies and Assays Market: Company Product Type Footprint
Table 16. Neuroscience Antibodies and Assays Market: Company Product Application Footprint
Table 17. Neuroscience Antibodies and Assays Mergers & Acquisitions Activity
Table 18. United States VS China Neuroscience Antibodies and Assays Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Neuroscience Antibodies and Assays Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Neuroscience Antibodies and Assays Companies, Headquarters (States, Country)
Table 21. United States Based Companies Neuroscience Antibodies and Assays Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Neuroscience Antibodies and Assays Revenue Market Share (2018-2023)
Table 23. China Based Neuroscience Antibodies and Assays Companies, Headquarters (Province, Country)
Table 24. China Based Companies Neuroscience Antibodies and Assays Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Neuroscience Antibodies and Assays Revenue Market Share (2018-2023)
Table 26. Rest of World Based Neuroscience Antibodies and Assays Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Neuroscience Antibodies and Assays Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Neuroscience Antibodies and Assays Revenue Market Share (2018-2023)
Table 29. World Neuroscience Antibodies and Assays Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Neuroscience Antibodies and Assays Market Size by Type (2018-2023) & (USD Million)
Table 31. World Neuroscience Antibodies and Assays Market Size by Type (2024-2029) & (USD Million)
Table 32. World Neuroscience Antibodies and Assays Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Neuroscience Antibodies and Assays Market Size by Application (2018-2023) & (USD Million)
Table 34. World Neuroscience Antibodies and Assays Market Size by Application (2024-2029) & (USD Million)
Table 35. Thermo Fisher Basic Information, Area Served and Competitors
Table 36. Thermo Fisher Major Business
Table 37. Thermo Fisher Neuroscience Antibodies and Assays Product and Services
Table 38. Thermo Fisher Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Thermo Fisher Recent Developments/Updates
Table 40. Thermo Fisher Competitive Strengths & Weaknesses
Table 41. Abcam Basic Information, Area Served and Competitors
Table 42. Abcam Major Business
Table 43. Abcam Neuroscience Antibodies and Assays Product and Services
Table 44. Abcam Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Abcam Recent Developments/Updates
Table 46. Abcam Competitive Strengths & Weaknesses
Table 47. Bio-Rad Basic Information, Area Served and Competitors
Table 48. Bio-Rad Major Business
Table 49. Bio-Rad Neuroscience Antibodies and Assays Product and Services
Table 50. Bio-Rad Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Bio-Rad Recent Developments/Updates
Table 52. Bio-Rad Competitive Strengths & Weaknesses
Table 53. Merck Basic Information, Area Served and Competitors
Table 54. Merck Major Business
Table 55. Merck Neuroscience Antibodies and Assays Product and Services
Table 56. Merck Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Merck Recent Developments/Updates
Table 58. Merck Competitive Strengths & Weaknesses
Table 59. Cell Signaling Technology Basic Information, Area Served and Competitors
Table 60. Cell Signaling Technology Major Business
Table 61. Cell Signaling Technology Neuroscience Antibodies and Assays Product and Services
Table 62. Cell Signaling Technology Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Cell Signaling Technology Recent Developments/Updates
Table 64. Cell Signaling Technology Competitive Strengths & Weaknesses
Table 65. Genscript Basic Information, Area Served and Competitors
Table 66. Genscript Major Business
Table 67. Genscript Neuroscience Antibodies and Assays Product and Services
Table 68. Genscript Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Genscript Recent Developments/Updates
Table 70. Genscript Competitive Strengths & Weaknesses
Table 71. Rockland Immunochemicals Basic Information, Area Served and Competitors
Table 72. Rockland Immunochemicals Major Business
Table 73. Rockland Immunochemicals Neuroscience Antibodies and Assays Product and Services
Table 74. Rockland Immunochemicals Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Rockland Immunochemicals Recent Developments/Updates
Table 76. Rockland Immunochemicals Competitive Strengths & Weaknesses
Table 77. BioLegend Basic Information, Area Served and Competitors
Table 78. BioLegend Major Business
Table 79. BioLegend Neuroscience Antibodies and Assays Product and Services
Table 80. BioLegend Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. BioLegend Recent Developments/Updates
Table 82. BioLegend Competitive Strengths & Weaknesses
Table 83. Santa Cruz Biotechnology Basic Information, Area Served and Competitors
Table 84. Santa Cruz Biotechnology Major Business
Table 85. Santa Cruz Biotechnology Neuroscience Antibodies and Assays Product and Services
Table 86. Santa Cruz Biotechnology Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Santa Cruz Biotechnology Recent Developments/Updates
Table 88. Santa Cruz Biotechnology Competitive Strengths & Weaknesses
Table 89. Roche Basic Information, Area Served and Competitors
Table 90. Roche Major Business
Table 91. Roche Neuroscience Antibodies and Assays Product and Services
Table 92. Roche Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Roche Recent Developments/Updates
Table 94. Siemens Basic Information, Area Served and Competitors
Table 95. Siemens Major Business
Table 96. Siemens Neuroscience Antibodies and Assays Product and Services
Table 97. Siemens Neuroscience Antibodies and Assays Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 98. Global Key Players of Neuroscience Antibodies and Assays Upstream (Raw Materials)
Table 99. Neuroscience Antibodies and Assays Typical Customers
List of Figure
Figure 1. Neuroscience Antibodies and Assays Picture
Figure 2. World Neuroscience Antibodies and Assays Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Neuroscience Antibodies and Assays Total Market Size (2018-2029) & (USD Million)
Figure 4. World Neuroscience Antibodies and Assays Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Neuroscience Antibodies and Assays Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Neuroscience Antibodies and Assays Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Neuroscience Antibodies and Assays Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Neuroscience Antibodies and Assays Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Neuroscience Antibodies and Assays Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Neuroscience Antibodies and Assays Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Neuroscience Antibodies and Assays Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Neuroscience Antibodies and Assays Revenue (2018-2029) & (USD Million)
Figure 13. Neuroscience Antibodies and Assays Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
Figure 16. World Neuroscience Antibodies and Assays Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
Figure 18. China Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
Figure 23. India Neuroscience Antibodies and Assays Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Neuroscience Antibodies and Assays by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Neuroscience Antibodies and Assays Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Neuroscience Antibodies and Assays Markets in 2022
Figure 27. United States VS China: Neuroscience Antibodies and Assays Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Neuroscience Antibodies and Assays Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Neuroscience Antibodies and Assays Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Neuroscience Antibodies and Assays Market Size Market Share by Type in 2022
Figure 31. Consumables
Figure 32. Instruments
Figure 33. World Neuroscience Antibodies and Assays Market Size Market Share by Type (2018-2029)
Figure 34. World Neuroscience Antibodies and Assays Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Neuroscience Antibodies and Assays Market Size Market Share by Application in 2022
Figure 36. Pharmaceutical & Biotechnology Companies
Figure 37. Academic & Research Institutes
Figure 38. Hospitals & Diagnostic Centers
Figure 39. Neuroscience Antibodies and Assays Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

jiaGou

Add To Cart

gouMai

Buy Now